Recently stock market analysts have updated their consensus ratings on shares of AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO).

Most recent broker ratings

03/30/2016 – FBR Capital Markets began new coverage on AVEO Pharmaceuticals, Inc. giving the company a “outperform” rating. They now have a USD 3 price target on the stock.

04/30/2015 – AVEO Pharmaceuticals, Inc. was downgraded to “buy” by analysts at Zacks. They now have a USD 2.25 price target on the stock.

03/09/2015 – AVEO Pharmaceuticals, Inc. was upgraded to “sector perform” by analysts at RBC Capital. They now have a USD 3 price target on the stock.

AVEO Pharmaceuticals, Inc. has a 50 day moving average of 0.97 and a 200 day moving average of 1.06. The stock’s market capitalization is 53.30M, it has a 52-week low of 0.82 and a 52-week high of 3.50.

The share price of the company (NASDAQ:AVEO) was down -0.36%, with a high of 0.95 during the day and the volume of AVEO Pharmaceuticals, Inc. shares traded was 139334.

View other investors thoughts on AVEO Pharmaceuticals, Inc. with our new Stock Talk discussion platform. Sign up for free to contribute to the community and view research provided from other investors for any stock listed on the LSE, NYSE or NASDAQ.